ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Hormone Therapy Drugs Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-38N14445
Home | Market Reports | Health| Health Conditions| Cancer
Global Cancer Hormone Therapy Drugs Market Insights Forecast to 2029
BUY CHAPTERS

Global Cancer Hormone Therapy Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-38N14445
Report
December 2024
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Amgen Inc
Pfizer Inc
TEVA
Takeda
Samyang Biopharmaceuticals
Tolmar
Astrazeneca plc
Novartis
Aspen

Cancer Hormone Therapy Drugs Market

Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer.
Market Analysis and Insights: Global Cancer Hormone Therapy Drugs Market
The global Cancer Hormone Therapy Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Cancer Hormone Therapy Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Cancer Hormone Therapy Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Cancer Hormone Therapy Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Cancer Hormone Therapy Drugs include Roche, Amgen, Pfizer, Teva, Takeda, Samyang Biopharmaceuticals, Tolmar, AstraZeneca and Novartis, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Cancer Hormone Therapy Drugs is widely used in various fields, such as Breast Cancer and Prostate Cancer, etc. Breast Cancer provides greatest supports to the Cancer Hormone Therapy Drugs industry development. In 2023, global % revenue of Cancer Hormone Therapy Drugs went into Breast Cancer filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Cancer Hormone Therapy Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Cancer Hormone Therapy Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cancer Hormone Therapy Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cancer Hormone Therapy Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cancer Hormone Therapy Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cancer Hormone Therapy Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Cancer Hormone Therapy Drugs Market Report

Report Metric Details
Report Name Cancer Hormone Therapy Drugs Market
Segment by Type
Segment by Application
  • Breast Cancer
  • Prostate Cancer
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Amgen, Pfizer, Teva, Takeda, Samyang Biopharmaceuticals, Tolmar, AstraZeneca, Novartis, Aspen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Cancer Hormone Therapy Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cancer Hormone Therapy Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Hormone Therapy Drugs revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Cancer Hormone Therapy Drugs Market report?

Ans: The main players in the Cancer Hormone Therapy Drugs Market are Roche, Amgen, Pfizer, Teva, Takeda, Samyang Biopharmaceuticals, Tolmar, AstraZeneca, Novartis, Aspen

What are the Application segmentation covered in the Cancer Hormone Therapy Drugs Market report?

Ans: The Applications covered in the Cancer Hormone Therapy Drugs Market report are Breast Cancer, Prostate Cancer

What are the Type segmentation covered in the Cancer Hormone Therapy Drugs Market report?

Ans: The Types covered in the Cancer Hormone Therapy Drugs Market report are Tamoxifen, Aromatase Inhibitors, Antiandrogens, Androgen Synthesis Inhibitors, Other

Recommended Reports

Cancer Drug Markets

Breast Cancer Solutions

Prostate Cancer Therapies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Tamoxifen
1.2.3 Aromatase Inhibitors
1.2.4 Antiandrogens
1.2.5 Androgen Synthesis Inhibitors
1.2.6 Other
1.3 Market by Application
1.3.1 Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Hormone Therapy Drugs Market Perspective (2019-2030)
2.2 Global Cancer Hormone Therapy Drugs Growth Trends by Region
2.2.1 Cancer Hormone Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Hormone Therapy Drugs Historic Market Size by Region (2019-2024)
2.2.3 Cancer Hormone Therapy Drugs Forecasted Market Size by Region (2025-2030)
2.3 Cancer Hormone Therapy Drugs Market Dynamics
2.3.1 Cancer Hormone Therapy Drugs Industry Trends
2.3.2 Cancer Hormone Therapy Drugs Market Drivers
2.3.3 Cancer Hormone Therapy Drugs Market Challenges
2.3.4 Cancer Hormone Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cancer Hormone Therapy Drugs by Players
3.1.1 Global Cancer Hormone Therapy Drugs Revenue by Players (2019-2024)
3.1.2 Global Cancer Hormone Therapy Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Hormone Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cancer Hormone Therapy Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Cancer Hormone Therapy Drugs Market Concentration Ratio
3.4.1 Global Cancer Hormone Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Hormone Therapy Drugs Revenue in 2023
3.5 Global Key Players of Cancer Hormone Therapy Drugs Head office and Area Served
3.6 Global Key Players of Cancer Hormone Therapy Drugs, Product and Application
3.7 Global Key Players of Cancer Hormone Therapy Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Hormone Therapy Drugs Breakdown Data by Type
4.1 Global Cancer Hormone Therapy Drugs Historic Market Size by Type (2019-2024)
4.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2025-2030)
5 Cancer Hormone Therapy Drugs Breakdown Data by Application
5.1 Global Cancer Hormone Therapy Drugs Historic Market Size by Application (2019-2024)
5.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Hormone Therapy Drugs Market Size (2019-2030)
6.2 North America Cancer Hormone Therapy Drugs Market Size by Type
6.2.1 North America Cancer Hormone Therapy Drugs Market Size by Type (2019-2024)
6.2.2 North America Cancer Hormone Therapy Drugs Market Size by Type (2025-2030)
6.2.3 North America Cancer Hormone Therapy Drugs Market Share by Type (2019-2030)
6.3 North America Cancer Hormone Therapy Drugs Market Size by Application
6.3.1 North America Cancer Hormone Therapy Drugs Market Size by Application (2019-2024)
6.3.2 North America Cancer Hormone Therapy Drugs Market Size by Application (2025-2030)
6.3.3 North America Cancer Hormone Therapy Drugs Market Share by Application (2019-2030)
6.4 North America Cancer Hormone Therapy Drugs Market Size by Country
6.4.1 North America Cancer Hormone Therapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)
6.4.3 North America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cancer Hormone Therapy Drugs Market Size (2019-2030)
7.2 Europe Cancer Hormone Therapy Drugs Market Size by Type
7.2.1 Europe Cancer Hormone Therapy Drugs Market Size by Type (2019-2024)
7.2.2 Europe Cancer Hormone Therapy Drugs Market Size by Type (2025-2030)
7.2.3 Europe Cancer Hormone Therapy Drugs Market Share by Type (2019-2030)
7.3 Europe Cancer Hormone Therapy Drugs Market Size by Application
7.3.1 Europe Cancer Hormone Therapy Drugs Market Size by Application (2019-2024)
7.3.2 Europe Cancer Hormone Therapy Drugs Market Size by Application (2025-2030)
7.3.3 Europe Cancer Hormone Therapy Drugs Market Share by Application (2019-2030)
7.4 Europe Cancer Hormone Therapy Drugs Market Size by Country
7.4.1 Europe Cancer Hormone Therapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)
7.4.3 Europe Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cancer Hormone Therapy Drugs Market Size (2019-2030)
8.2 China Cancer Hormone Therapy Drugs Market Size by Type
8.2.1 China Cancer Hormone Therapy Drugs Market Size by Type (2019-2024)
8.2.2 China Cancer Hormone Therapy Drugs Market Size by Type (2025-2030)
8.2.3 China Cancer Hormone Therapy Drugs Market Share by Type (2019-2030)
8.3 China Cancer Hormone Therapy Drugs Market Size by Application
8.3.1 China Cancer Hormone Therapy Drugs Market Size by Application (2019-2024)
8.3.2 China Cancer Hormone Therapy Drugs Market Size by Application (2025-2030)
8.3.3 China Cancer Hormone Therapy Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Cancer Hormone Therapy Drugs Market Size (2019-2030)
9.2 Asia Cancer Hormone Therapy Drugs Market Size by Type
9.2.1 Asia Cancer Hormone Therapy Drugs Market Size by Type (2019-2024)
9.2.2 Asia Cancer Hormone Therapy Drugs Market Size by Type (2025-2030)
9.2.3 Asia Cancer Hormone Therapy Drugs Market Share by Type (2019-2030)
9.3 Asia Cancer Hormone Therapy Drugs Market Size by Application
9.3.1 Asia Cancer Hormone Therapy Drugs Market Size by Application (2019-2024)
9.3.2 Asia Cancer Hormone Therapy Drugs Market Size by Application (2025-2030)
9.3.3 Asia Cancer Hormone Therapy Drugs Market Share by Application (2019-2030)
9.4 Asia Cancer Hormone Therapy Drugs Market Size by Region
9.4.1 Asia Cancer Hormone Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Cancer Hormone Therapy Drugs Market Size by Region (2019-2024)
9.4.3 Asia Cancer Hormone Therapy Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Cancer Hormone Therapy Drugs Introduction
11.1.4 Roche Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.1.5 Roche Recent Developments
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Cancer Hormone Therapy Drugs Introduction
11.2.4 Amgen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.2.5 Amgen Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Cancer Hormone Therapy Drugs Introduction
11.3.4 Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.3.5 Pfizer Recent Developments
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Cancer Hormone Therapy Drugs Introduction
11.4.4 Teva Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.4.5 Teva Recent Developments
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Cancer Hormone Therapy Drugs Introduction
11.5.4 Takeda Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.5.5 Takeda Recent Developments
11.6 Samyang Biopharmaceuticals
11.6.1 Samyang Biopharmaceuticals Company Details
11.6.2 Samyang Biopharmaceuticals Business Overview
11.6.3 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Introduction
11.6.4 Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.6.5 Samyang Biopharmaceuticals Recent Developments
11.7 Tolmar
11.7.1 Tolmar Company Details
11.7.2 Tolmar Business Overview
11.7.3 Tolmar Cancer Hormone Therapy Drugs Introduction
11.7.4 Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.7.5 Tolmar Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Cancer Hormone Therapy Drugs Introduction
11.8.4 AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.8.5 AstraZeneca Recent Developments
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Cancer Hormone Therapy Drugs Introduction
11.9.4 Novartis Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.9.5 Novartis Recent Developments
11.10 Aspen
11.10.1 Aspen Company Details
11.10.2 Aspen Business Overview
11.10.3 Aspen Cancer Hormone Therapy Drugs Introduction
11.10.4 Aspen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.10.5 Aspen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Roche
Amgen Inc
Pfizer Inc
TEVA
Takeda
Samyang Biopharmaceuticals
Tolmar
Astrazeneca plc
Novartis
Aspen
List of Tables
    Table 1. Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Tamoxifen
    Table 3. Key Players of Aromatase Inhibitors
    Table 4. Key Players of Antiandrogens
    Table 5. Key Players of Androgen Synthesis Inhibitors
    Table 6. Key Players of Other
    Table 7. Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Cancer Hormone Therapy Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Cancer Hormone Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Cancer Hormone Therapy Drugs Market Share by Region (2019-2024)
    Table 11. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Cancer Hormone Therapy Drugs Market Share by Region (2025-2030)
    Table 13. Cancer Hormone Therapy Drugs Market Trends
    Table 14. Cancer Hormone Therapy Drugs Market Drivers
    Table 15. Cancer Hormone Therapy Drugs Market Challenges
    Table 16. Cancer Hormone Therapy Drugs Market Restraints
    Table 17. Global Cancer Hormone Therapy Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Cancer Hormone Therapy Drugs Revenue Share by Players (2019-2024)
    Table 19. Global Top Cancer Hormone Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Hormone Therapy Drugs as of 2023)
    Table 20. Global Cancer Hormone Therapy Drugs Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Cancer Hormone Therapy Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Cancer Hormone Therapy Drugs, Headquarters and Area Served
    Table 23. Global Key Players of Cancer Hormone Therapy Drugs, Product and Application
    Table 24. Global Key Players of Cancer Hormone Therapy Drugs, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Cancer Hormone Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type (2019-2024)
    Table 28. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type (2025-2030)
    Table 30. Global Cancer Hormone Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Cancer Hormone Therapy Drugs Revenue Share by Application (2019-2024)
    Table 32. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Cancer Hormone Therapy Drugs Revenue Share by Application (2025-2030)
    Table 34. North America Cancer Hormone Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Cancer Hormone Therapy Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Cancer Hormone Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Cancer Hormone Therapy Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Cancer Hormone Therapy Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Cancer Hormone Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Cancer Hormone Therapy Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Cancer Hormone Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Cancer Hormone Therapy Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Cancer Hormone Therapy Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Cancer Hormone Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Cancer Hormone Therapy Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Cancer Hormone Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Cancer Hormone Therapy Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Cancer Hormone Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Cancer Hormone Therapy Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Cancer Hormone Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Cancer Hormone Therapy Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Cancer Hormone Therapy Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Cancer Hormone Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Cancer Hormone Therapy Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Roche Company Details
    Table 67. Roche Business Overview
    Table 68. Roche Cancer Hormone Therapy Drugs Product
    Table 69. Roche Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
    Table 70. Roche Recent Developments
    Table 71. Amgen Company Details
    Table 72. Amgen Business Overview
    Table 73. Amgen Cancer Hormone Therapy Drugs Product
    Table 74. Amgen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
    Table 75. Amgen Recent Developments
    Table 76. Pfizer Company Details
    Table 77. Pfizer Business Overview
    Table 78. Pfizer Cancer Hormone Therapy Drugs Product
    Table 79. Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
    Table 80. Pfizer Recent Developments
    Table 81. Teva Company Details
    Table 82. Teva Business Overview
    Table 83. Teva Cancer Hormone Therapy Drugs Product
    Table 84. Teva Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
    Table 85. Teva Recent Developments
    Table 86. Takeda Company Details
    Table 87. Takeda Business Overview
    Table 88. Takeda Cancer Hormone Therapy Drugs Product
    Table 89. Takeda Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
    Table 90. Takeda Recent Developments
    Table 91. Samyang Biopharmaceuticals Company Details
    Table 92. Samyang Biopharmaceuticals Business Overview
    Table 93. Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Product
    Table 94. Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
    Table 95. Samyang Biopharmaceuticals Recent Developments
    Table 96. Tolmar Company Details
    Table 97. Tolmar Business Overview
    Table 98. Tolmar Cancer Hormone Therapy Drugs Product
    Table 99. Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
    Table 100. Tolmar Recent Developments
    Table 101. AstraZeneca Company Details
    Table 102. AstraZeneca Business Overview
    Table 103. AstraZeneca Cancer Hormone Therapy Drugs Product
    Table 104. AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
    Table 105. AstraZeneca Recent Developments
    Table 106. Novartis Company Details
    Table 107. Novartis Business Overview
    Table 108. Novartis Cancer Hormone Therapy Drugs Product
    Table 109. Novartis Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
    Table 110. Novartis Recent Developments
    Table 111. Aspen Company Details
    Table 112. Aspen Business Overview
    Table 113. Aspen Cancer Hormone Therapy Drugs Product
    Table 114. Aspen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
    Table 115. Aspen Recent Developments
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Cancer Hormone Therapy Drugs Market Share by Type: 2023 VS 2030
    Figure 3. Tamoxifen Features
    Figure 4. Aromatase Inhibitors Features
    Figure 5. Antiandrogens Features
    Figure 6. Androgen Synthesis Inhibitors Features
    Figure 7. Other Features
    Figure 8. Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Cancer Hormone Therapy Drugs Market Share by Application: 2023 VS 2030
    Figure 10. Breast Cancer Case Studies
    Figure 11. Prostate Cancer Case Studies
    Figure 12. Cancer Hormone Therapy Drugs Report Years Considered
    Figure 13. Global Cancer Hormone Therapy Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Cancer Hormone Therapy Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Cancer Hormone Therapy Drugs Market Share by Region: 2023 VS 2030
    Figure 16. Global Cancer Hormone Therapy Drugs Market Share by Players in 2023
    Figure 17. Global Top Cancer Hormone Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Hormone Therapy Drugs as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Cancer Hormone Therapy Drugs Revenue in 2023
    Figure 19. North America Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Cancer Hormone Therapy Drugs Market Share by Type (2019-2030)
    Figure 21. North America Cancer Hormone Therapy Drugs Market Share by Application (2019-2030)
    Figure 22. North America Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)
    Figure 23. United States Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Cancer Hormone Therapy Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Cancer Hormone Therapy Drugs Market Share by Type (2019-2030)
    Figure 27. Europe Cancer Hormone Therapy Drugs Market Share by Application (2019-2030)
    Figure 28. Europe Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)
    Figure 29. Germany Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Cancer Hormone Therapy Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Cancer Hormone Therapy Drugs Market Share by Type (2019-2030)
    Figure 37. China Cancer Hormone Therapy Drugs Market Share by Application (2019-2030)
    Figure 38. Asia Cancer Hormone Therapy Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Cancer Hormone Therapy Drugs Market Share by Type (2019-2030)
    Figure 40. Asia Cancer Hormone Therapy Drugs Market Share by Application (2019-2030)
    Figure 41. Asia Cancer Hormone Therapy Drugs Market Share by Region (2019-2030)
    Figure 42. Japan Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)
    Figure 52. Brazil Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Roche Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
    Figure 59. Amgen Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
    Figure 60. Pfizer Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
    Figure 61. Teva Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
    Figure 62. Takeda Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
    Figure 63. Samyang Biopharmaceuticals Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
    Figure 64. Tolmar Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
    Figure 65. AstraZeneca Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
    Figure 66. Novartis Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
    Figure 67. Aspen Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Breast Cancer Hormone Therapy Market Insights Forecast to 2030
Prostate Cancer Hormone Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Endocrine Therapy Medication Market Research Report 2024
Global Antihormonal Cancer Therapies Market Insights Forecast to 2030
Global Hormone Replacement Therapy Market Insights Forecast to 2030
Global Drugs For Hormonal Replacement Market Insights Forecast to 2030
Hormone Replacement Therapy HRT Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Treatment Drugs Market
Global Androgen Suppression Therapy Market Insights Forecast to 2030
Hormone Replacement Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hormonal Drugs Market Research Report 2025
Hormone Replacement Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hormone Pellet Therapy Market Research Report 2024
Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030
Global External beam Radiation Therapy Market Insights Forecast to 2030
Endocrine Therapy Drugs ETDs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Steroid Hormone Drugs Market Research Report 2024
Global Endocrine Therapy Drugs for Breast Cancer Market Research Report 2024
Global Breast Cancer Drugs Market Insights Forecast to 2030
Global Cancer Biotherapy Market Insights Forecast to 2030

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions